Bio-Techne (TECH) Cash from Investing Activities Growth (3y) (2012 - 2026)
Bio-Techne (TECH) Cash from Investing Activities Growth (3y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
116.52% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
38.24% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Bio-Techne |
9.04 Bn |
8.83 Bn |
208.29 Mn |
71.10% |
| Date | Value |
|---|
| Mar 31, 2026 |
71.10% |
| Dec 31, 2025 |
-278.72% |
| Sep 30, 2025 |
26.63% |
| Jun 30, 2025 |
26.45% |
| Mar 31, 2025 |
37.30% |
| Dec 31, 2024 |
47.70% |
| Sep 30, 2024 |
-44.95% |
| Jun 30, 2024 |
66.14% |
| Mar 31, 2024 |
-405.86% |
| Dec 31, 2023 |
-40.12% |
| Sep 30, 2023 |
-166.55% |
| Jun 30, 2023 |
23.14% |
| Mar 31, 2023 |
-143.60% |
| Dec 31, 2022 |
-26.06% |
| Sep 30, 2022 |
-9.28% |
| Jun 30, 2022 |
15.07% |
| Mar 31, 2022 |
-96.61% |
| Dec 31, 2021 |
-37.14% |
| Sep 30, 2021 |
70.87% |
| Jun 30, 2021 |
-99.80% |
